Posters & Publications

Years of Research at Your Fingertips

ProMIS Neurosciences’ publications and posters provide ample background on our research surrounding neurodegenerative diseases.

Filter By:

Poster

Phase 1a Single Ascending Dose Study of PMN310, a monoclonal antibody directed against toxic Aβ oligomers

See Poster
Presentation

Distinguishing between Ab-directed antibodies: Ability of PMN310 to target toxic oligomers despite competing species

View Presentation
Poster

Novel approach to optimization of Alzheimer’s vaccine configuration for maximal targeting of toxic amyloid-beta oligomers

See Poster
Manuscript

Relationship between therapeutic activity and preferential targeting of toxic soluble aggregates by amyloid-beta-directed antibodies

View Manuscript
Publication

Targeting RACK1 to alleviate TDP-43 and FUS proteinopathy-mediated suppression of protein translation and neurodegeneration

View Publication
Poster

Selective targeting and protection against toxic amyloid-beta oligomers by PMN310, a monoclonal antibody rationally designed for greater therapeutic potency in Alzheimer’s disease

See Poster
Poster

Rational design of a vaccine for Alzheimer’s disease using a computationallyderived conformational epitope to selectively target toxic amyloid-beta oligomers

See Poster
Presentation

AAN 2023 Presentation – Rational design of a vaccine for Alzheimer’s disease using computationally-derived conformational B cell epitopes to selectively target toxic amyloid-beta oligomers

View Presentation
Poster

AAN 2023 Poster – RACK1 Knockdown is a Potential Therapeutic Target in ALS and FTLD-TDP

See Poster
Poster

AAN 2023 Poster – Protection against toxic amyloid-beta oligomers by PMN310 in Alzheimer’s disease

See Poster
Poster

AD/PD 2023 Poster

See Poster
Manuscript

Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein

View Manuscript